Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Novo Nordisk ADR (NYSE: NVO) closed at $68.17 in the last session, down -0.04% from day before closing price of $68.20. In other words, the price has decreased by -$0.04 from its previous closing price. On the day, 7.18 million shares were traded.
Ratios:
We take a closer look at NVO’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 38.14 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.06. For the most recent quarter (mrq), Quick Ratio is recorded 0.56 and its Current Ratio is at 0.74. In the meantime, Its Debt-to-Equity ratio is 0.86 whereas as Long-Term Debt/Eq ratio is at 0.70.
Valuation Measures:
As of this moment, Novo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.22, and their Forward P/E ratio for the next fiscal year is 14.47. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.26 while its Price-to-Book (P/B) ratio in mrq is 15.09.
Stock Price History:
Over the past 52 weeks, NVO has reached a high of $148.15, while it has fallen to a 52-week low of $57.00. The 50-Day Moving Average of the stock is 0.88%, while the 200-Day Moving Average is calculated to be -29.82%.
Shares Statistics:
A total of 3.37B shares are outstanding, with a floating share count of 3.37B. Insiders hold about 0.00% of the company’s shares, while institutions hold 9.73% stake in the company.
